Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

New diabetes tech and therapies improve care for endocrine disorders.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

New acne treatments show promise as alternatives to traditional therapies.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

New and repurposed treatments are improving outcomes in dermatology.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Tridax procumbens significantly lowers blood sugar in diabetic rats.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

Eating less calories, focusing on complex carbs, and reducing fats can help manage type II diabetes.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Combining lifestyle changes with personalized medication is crucial for better managing obesity in PCOS.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

Weight-loss drugs are not linked to suicidal thoughts.